Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Randy Sutton
Opinion: If you are concerned about RINOs in the Republican Party, support the Open Primaries Initiative
Many of our fellow Republicans, including our current state party leadership, are concerned that other Republicans, particularly some of those holding elected positions, are not Republican enough. They call them RINOs, support party rules allowing the party to discipline elected officials or even to prevent those deemed insufficiently Republican from running in general elections as Republicans.
Think of the kids: New restrictions on food and drink advertising to children
Children are generally recognized by both industry and government to be a vulnerable or special audience when it comes to advertising. On June 28, 2023, a new advertising code will be coming into effect as released by Ad Standards Canada. It is intended to expand upon legislative, regulatory, and self-regulatory regimes that already exist in Canada (including in Quebec).
Summary judgment puts brakes on misleading advertising class action
Get free access to The Lawyer's Daily Enter your details below and select your area(s) of interest to receive daily newsletters PLEASE NOTE: A verification email will be sent to your address before you can access your trial. LexisNexis may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.
Health Canada Consults On Proposed Guidelines For The Use Of Electronic Media In Prescription Drug Labelling
Canada: Health Canada Consults On Proposed Guidelines For The Use Of Electronic Media In Prescription Drug Labelling 22 March 2021 by Sarah Pennington , John Greiss and Randy Sutton Norton Rose Fulbright Canada LLP Your LinkedIn Connections with the authors To print this article, all you need is to be registered or login on Mondaq.com.
Health Canada consults on proposed guidelines for the use of electronic media in prescription drug labelling
Health Canada is seeking input from industry stakeholders on a new draft guidance document that discusses the use of electronic media in prescription drug labelling. The intent of the draft guidance document is to describe Health Canada’s expectations for manufacturers who distribute prescription drug information through an electronic means, such as a website or mobile app, that is directly linked to a product’s packaging or label.
Arbitrating disputes in pharmaceutical, life sciences and healthcare sector during COVID-19 pandemic | Lexology
Introduction A signature feature of the last several months has been the scramble for personal protective equipment (PPE) such as masks, shields and gowns for doctors, nurses and other care workers. Governments have been focused on ensuring that health authorities, both public and private, have a sufficient supply of essential medical equipment (eg, PPE and ventilators) and pharmaceutical products to deal with the initial surge of COVID-19 cases.
Significant amendments coming to Ontario’s Class Proceedings Act, 1992
On July 8, Bill 161, the Smarter and Stronger Justice Act, 2020 (the SSJA), passed a third reading in the Ontario provincial legislature and received royal assent, becoming law. The SSJA includes significant amendments to Ontario’s Class Proceedings Act, 1992 (CPA), marking the first time that Ontario’s class action legislation has undergone major changes since its enactment over 27 years ago. To learn more about these amendments, please refer to our legal update.
Significant amendments coming to Ontario’s Class Proceedings Act, 1992
On July 8, Bill 161, the Smarter and Stronger Justice Act, 2020 (the SSJA), passed a third reading in the Ontario provincial legislature and received royal assent, becoming law. The SSJA includes significant amendments to Ontario’s Class Proceedings Act, 1992 (CPA), marking the first time that Ontario’s class action legislation has undergone major changes since its enactment over 27 years ago. To learn more about these amendments, please refer to our legal update.
Ontario Passes Significant Amendments To Class Proceedings Act
To print this article, all you need is to be registered or login on Mondaq.com. On July 8, Bill 161, the Smarter and Stronger Justice Act, 2020 (the SSJA), passed a third reading in the Ontario provincial legislature and received royal assent, becoming law. The SSJA includes significant amendments to Ontario's Class Proceedings Act, 1992 (CPA), marking the first time that Ontario's class action legislation has undergone major changes since its enactment over 27 years ago.
Ontario Lifts Recommendation To Limit Prescription Dispensing To 30 Days' Supply
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Ontario lifts recommendation to limit prescription dispensing to 30 days’ supply
We previously reported on the Ontario government’s efforts to manage the risk of drug shortages in the early days of the pandemic. Those efforts included a recommendation that pharmacies dispense no more than a 30-days’ supply of medication to patients under the Ontario Drug Benefit (ODB) program.
Arbitrating Disputes In The Pharmaceutical, Life Sciences And Healthcare Sector In The Era Of The COVID-19 Pandemic
To print this article, all you need is to be registered or login on Mondaq.com. Introduction A signature feature of the last several months has been the scramble for masks, shields and gowns – personal protective equipment (PPE) – for doctors, nurses and other care workers.
Arbitrating disputes in the pharmaceutical, life sciences and healthcare sector in the era of the COVID-19 pandemic
Introduction A signature feature of the last several months has been the scramble for masks, shields and gowns – personal protective equipment (PPE) – for doctors, nurses and other care workers. Governments have been focused on ensuring that health authorities, both public and private, have a sufficient supply of essential medical equipment (such as PPE and ventilators) and pharmaceutical products to deal with the initial surge of COVID-19 cases.
Health Canada amends regulations to permit distribution of OTC and NHP samples to general public
Health Canada has finalized amendments to the Food and Drug Regulations (FDR) and Natural Health Product Regulations (NHPR) to allow for the distribution of samples of non-prescription drugs (NPDs, or “over-the-counter” (OTC) drugs) and natural health products (NHPs) to a larger scope of healthcare professionals as well as the general public. Previously, the distribution of these products was limited to physicians, dentists, veterinary surgeons and pharmacists.
Html.Raw(Health Canada Releases Guidance Document Addressing The Plain Language Labelling Regulations Requirements For Non-Prescription Drug Products - Food, Drugs, Healthcare, Life Sciences - Canada)
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Html.Raw(Health Canada Issues Interim Order To Address Shortages Of Health Products - Food, Drugs, Healthcare, Life Sciences - Canada)
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Health Canada releases Guidance Document addressing the Plain Language Labelling Regulations requirements for non-prescription drug products
Health Canada recently published a new Guidance Document that provides information on how Health Canada interprets and applies the 2014 Regulations Amending the Food and Drug Regulations (Labelling, Packaging and Brand Names of Drugs for Human Use) (colloquially known as the Plain Language Labelling Regulations or PLL Regulations) for non-prescription (i.e. over-the-counter or OTC) drug products.
Health Canada issues Interim Order to address shortages of health products
Health Canada has published an Interim Order Respecting Drugs, Medical Devices and Foods for a Special Dietary Purpose in Relation to COVID-19 (the Interim Order). This Interim Order allows Health Canada and the Canadian Food Inspection Agency to address critical supply issues in an expedited manner when shortages occur. It was signed by the Minister on March 30, 2020.
Ontario And Quebec Introduce Changes To Pharmacy Practice And Highlight The Drug Supply Chain As An Essential Service
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
Ontario and Quebec Introduce Changes to Pharmacy Practice and Highlight the Drug Supply Chain as an Essential Service
The Government of Ontario has made changes to the Ontario Drug Benefit (ODB) Program in an effort to reduce the risk of drug shortages in the province during the COVID-19 outbreak. Effective immediately, ODB eligible drugs are subject to the following changes to rules on dispensing and fees: The dispensing of medication is limited to no more than a 30-days’ supply.
COVID-19: Health Canada Simplifies Regulatory Requirements For COVID-19-Related Products
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
COVID-19: Health Canada simplifies regulatory requirements for COVID-19-related products
Health Canada is taking measures to help expedite the importation and sale of certain licensed products required to combat COVID-19. Expedited review of Health Product Submissions and Applications Health Canada has announced that it will expedite the review of any COVID-19 related vaccines, therapeutic products and other health product submissions and applications.
COVID-19: Sharing information for licensed health products during a pandemic
The public health call for social distancing to help curb the COVID-19 pandemic has no doubt already affected how companies will be sharing information about pharmaceuticals and other licensed health products with healthcare professionals (HCPs), patients, and the public. As industry plays its part in keeping sales representatives and medical science liaisons (MSLs) home to help “flatten the curve”, many interactions between HCPs and companies are moving to the virtual world.
COVID-19: Health Canada Issues Bulletin Confirming Obligations Of DEL Holders
Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice): Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below. Mondaq has a "free to view" business model.
COVID-19: Health Canada Issues Bulletin Confirming Obligations of DEL Holders
In light of recent developments relating to the to the 2019 novel coronavirus (COVID-19), Health Canada recently sent a reminder to all Drug Establishment License (DEL) holders of their obligations under the Food and Drug Regulations (FDR) regarding reporting of events that could affect operations and lead to shortages or issues affecting quality, safety, and efficacy of products.
Ontario reduces restrictions on ordinary commercial term benefits and private label products
The Ontario Ministry of Health and Long-Term Care (the Ministry) introduced changes to regulations (collectively, the Regulations) made under the Ontario Drug Benefit Act (ODBA) and the Drug Interchangeability and Dispensing Fee Act (DIDFA). These changes will remove the financial caps on ordinary commercial term (OCT) payments made by drug manufacturers to pharmacies and allow private label products to be listed as benefits or be designated as “interchangeable”.
Reforming Class Actions in Ontario - Your Input Please!
On March 9, 2018, the Law Commission of Ontario (LCO) released its Consultation Paper entitled “Class Actions: Objectives, Experiences and Reforms”. The Consultation Paper is the next phase of the LCO’s Class Actions Project which is set to conduct a general review of the class action landscape in Ontario, with a view to providing a final report with recommendations for law reform where appropriate.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Randy
Contact Randy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack